CN101516864A - 坎地沙坦西来替昔酯晶型ⅰ的制备方法 - Google Patents

坎地沙坦西来替昔酯晶型ⅰ的制备方法 Download PDF

Info

Publication number
CN101516864A
CN101516864A CNA2007800341466A CN200780034146A CN101516864A CN 101516864 A CN101516864 A CN 101516864A CN A2007800341466 A CNA2007800341466 A CN A2007800341466A CN 200780034146 A CN200780034146 A CN 200780034146A CN 101516864 A CN101516864 A CN 101516864A
Authority
CN
China
Prior art keywords
former times
come
candesartan
ester
candesartan cilexetil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800341466A
Other languages
English (en)
Chinese (zh)
Inventor
西尔沃·祖普契奇
普里莫兹·贝恩基克
波拉纳·斯姆尔科尔伊
苏扎纳·塞尼卡尔
尼韦斯·绍什塔里奇-维尔兹
耶尔内伊·赫娃拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KRKA dd
Original Assignee
KRKA Tovarna Zdravil dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KRKA Tovarna Zdravil dd filed Critical KRKA Tovarna Zdravil dd
Publication of CN101516864A publication Critical patent/CN101516864A/zh
Pending legal-status Critical Current

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNA2007800341466A 2006-07-28 2007-07-27 坎地沙坦西来替昔酯晶型ⅰ的制备方法 Pending CN101516864A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SI200600176A SI22340A (sl) 2006-07-28 2006-07-28 Postopki za pripravo amorfnih in kristalnih oblikkandesartan cileksetila
SIP200600176 2006-07-28
SIP200700068 2007-03-20
SIP200700126 2007-05-30

Publications (1)

Publication Number Publication Date
CN101516864A true CN101516864A (zh) 2009-08-26

Family

ID=39357032

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800341466A Pending CN101516864A (zh) 2006-07-28 2007-07-27 坎地沙坦西来替昔酯晶型ⅰ的制备方法

Country Status (2)

Country Link
CN (1) CN101516864A (sl)
SI (1) SI22340A (sl)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103396407A (zh) * 2013-08-07 2013-11-20 迪沙药业集团有限公司 一种坎地沙坦酯晶体的制备方法
CN106866633A (zh) * 2017-02-20 2017-06-20 威海迪素制药有限公司 一种高纯度坎地沙坦酯晶型i的制备方法
CN110501449A (zh) * 2019-07-26 2019-11-26 威海迪素制药有限公司 一种坎地沙坦酯基因毒性杂质的检测方法
CN111943937A (zh) * 2020-09-26 2020-11-17 浙江金立源药业有限公司 三苯基坎地沙坦的合成方法

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103396407A (zh) * 2013-08-07 2013-11-20 迪沙药业集团有限公司 一种坎地沙坦酯晶体的制备方法
CN106866633A (zh) * 2017-02-20 2017-06-20 威海迪素制药有限公司 一种高纯度坎地沙坦酯晶型i的制备方法
CN110501449A (zh) * 2019-07-26 2019-11-26 威海迪素制药有限公司 一种坎地沙坦酯基因毒性杂质的检测方法
CN111943937A (zh) * 2020-09-26 2020-11-17 浙江金立源药业有限公司 三苯基坎地沙坦的合成方法

Also Published As

Publication number Publication date
SI22340A (sl) 2008-02-29

Similar Documents

Publication Publication Date Title
US9550735B2 (en) Process for the preparation of ivacaftor and solvates thereof
CN113773304B (zh) 抗耐药抗肿瘤egfr抑制剂的制备方法
EP2004602A1 (en) Salts with crth2 antagonist activity
JPH06505715A (ja) 化合物
US20140309221A1 (en) Method of inhibiting hamartoma tumor cells
US10745389B2 (en) HDAC6 selective inhibitors, preparation method therefor, and application thereof
EP2240469A2 (en) Substantially pure and a stable crystalline form of bosentan
WO2011049127A1 (ja) 炭化水素環基を有する５－ヒドロキシピリミジン－４－カルボキサミド誘導体
CN111606889B (zh) 4-(1-环丙基-1h-吲哚-3-基)-n-苯基嘧啶-2-胺衍生物的制备方法
WO2022114164A1 (ja) ヘテロアリールカルボキシアミド化合物
CN104418807A (zh) 一种2-乙氧基-1-[[2`-(羟基脒基)-联苯基]-4-基]甲基-1h-苯并咪唑-7-羧酸及其酯衍生物的制备方法
CN101516864A (zh) 坎地沙坦西来替昔酯晶型ⅰ的制备方法
US10654876B2 (en) TH-302 solid forms and methods related thereto
US6825214B2 (en) Substantially pure cilostazol and processes for making same
CN114929232B (zh) 一种吡啶并嘧啶类衍生物的结晶形式及其制备方法
WO2004062571A2 (en) Substantially pure cilostazol and processes for making same
TWI773987B (zh) 二胺基嘧啶類化合物或其水合物的固體形式及其製備方法和用途
EP1589966B1 (en) Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods
WO2008012372A1 (en) Process for the preparation of candesartan cilexetil form i
EP3057949B1 (en) Secondary alcohol quinolinyl modulators of ror gamma t
EP1945629A1 (en) Process for the preparation of candesartan cilexetil
CN100577661C (zh) 取代的8-氮杂双环[3.2.1]辛-3-醇的制备方法
WO2011088075A2 (en) Novel salts, polymorphs, and synthetic processes regarding imidazole derivative
AU2011379300A1 (en) Acid addition salts of Bosentan
RU2772274C2 (ru) Селективные ингибиторы hdac6, способ их получения и их применение

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090826